Evaluate Efficacy of US-guided PRP and MFAT Injections for Patients with Abnormal SI Ligamentous Laxity
Dr. Timothy Mazzola
MD, Penn State University College of Medicine
Triple board-certified in family medicine, sports medicine, and musculoskeletal ultrasound. Practices as a non-operative orthopedic and regenerative medicine specialist at Breakthrough Regenerative Orthopedics in Boulder, Colorado. Assistant clinical professor at the University of Colorado. National expert and highly sought-after physician educator who has taught musculoskeletal and sports ultrasound at the Gulfcoast Ultrasound Institute and Advanced US courses at the American Medical Society of Sports Medicine National Conferences.
Instability of the sacroiliac (SI) ligament and its myofascial attachments can induce pain and dysfunction in the lower back, hip and knee regions. Treatment of the secondary symptomatic areas, as opposed to the SI ligament and myofascial attachments, fails to address the primary root cause of pain and dysfunction in these regions.
This Circle uses a unique physical examination objective measurement, “Millimeters of Motion,” to quantify SI ligamentous laxity prior to and following orthobiologics treatments, including platelet-rich plasma (PRP) and micro-fragmented adipose tissue (MFAT) injections. The study further captures validated patient-reported outcomes of lower back, hip and overall pain levels over a 12-month period.
Observational, Quality Improvement
- Access to education on how to assess for SI ligamentous laxity.
- Access to a retrospective database demonstrating reduction of laxity and patient symptoms following orthobiologics treatment options.
- Turnkey solution for engaging your own everyday patients in self-reported outcomes tracking.
- Benchmarking of results and methods against all other Circle contributors.
- Access to innovative biological products involved within the study.
- Visual Analogue Scale (VAS)
- Revised Oswestry Disability Index (ODI)
- Hip Dysfunction and Osteoarthritis Outcome Score for Joint Replacement (HOOS, JR)
Private Circle
Evaluate Efficacy of US-guided PRP and MFAT Injections for Patients with Abnormal SI Ligamentous Laxity
Instability of the sacroiliac (SI) ligament and its myofascial attachments can induce pain and dysfunction in the lower back, hip and knee regions. Treatment of the secondary symptomatic areas, as opposed to the SI ligament and myofascial attachments, fails to address the primary root cause of pain and dysfunction in these regions.
This Circle uses a unique physical examination objective measurement, “Millimeters of Motion,” to quantify SI ligamentous laxity prior to and following orthobiologics treatments, including platelet-rich plasma (PRP) and micro-fragmented adipose tissue (MFAT) injections. The study further captures validated patient-reported outcomes of lower back, hip and overall pain levels over a 12-month period.
VAS; ODI; HOOS, Jr
- Access to education on how to assess for SI ligamentous laxity.
- Access to a retrospective database demonstrating reduction of laxity and patient symptoms following orthobiologics treatment options.
- Turnkey solution for engaging your own everyday patients in self-reported outcomes tracking.
- Benchmarking of results and methods against all other Circle contributors.
- Access to innovative biological products involved within the study.
Streamlined patient enrollment, real-world data capturing, heightened recognition, prominence and collaboration
Private Circle
CIRCLE LIBRARY
CIRCLE NAME
Total Knee Arthroplasty Outcome-Based Performance Measure
SURVEYS
VAS
KOOS Jr.
VR-12 (compliant with CMS/IQR Requirements)
As specified by Provider
THIS CIRCLE IS FOR:
Provider Receiving CMS Reimbursement For TKAs
CMS will soon penalize providers performing total knee replacements which do not collect specified outcomes data from at least 50% of qualifying patients.
Other Providers Performing TKAs
Private insurance companies and other payers within and outside the U.S. will follow the CMS lead in requiring high patient compliance in reporting long-term TKA outcomes.
WHY CIRCLES
If you have any questions, please contact us.